KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Takeda Pharmaceutical (TAK) Non-Current Assets (2017 - 2025)

Historic Non-Current Assets for Takeda Pharmaceutical (TAK) over the last 9 years, with Q4 2025 value amounting to $79.9 billion.

  • Takeda Pharmaceutical's Non-Current Assets fell 171.22% to $79.9 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $79.9 billion, marking a year-over-year decrease of 171.22%. This contributed to the annual value of $77.0 billion for FY2025, which is 1153.43% down from last year.
  • Takeda Pharmaceutical's Non-Current Assets amounted to $79.9 billion in Q4 2025, which was down 171.22% from $78.4 billion recorded in Q3 2025.
  • Takeda Pharmaceutical's 5-year Non-Current Assets high stood at $96.4 billion for Q1 2021, and its period low was $76.9 billion during Q1 2025.
  • Over the past 5 years, Takeda Pharmaceutical's median Non-Current Assets value was $85.2 billion (recorded in 2024), while the average stood at $85.0 billion.
  • Per our database at Business Quant, Takeda Pharmaceutical's Non-Current Assets crashed by 1412.22% in 2022 and then soared by 333.39% in 2023.
  • Quarter analysis of 5 years shows Takeda Pharmaceutical's Non-Current Assets stood at $89.9 billion in 2021, then decreased by 14.12% to $77.2 billion in 2022, then rose by 3.33% to $79.8 billion in 2023, then grew by 1.83% to $81.3 billion in 2024, then fell by 1.71% to $79.9 billion in 2025.
  • Its Non-Current Assets stands at $79.9 billion for Q4 2025, versus $78.4 billion for Q3 2025 and $79.4 billion for Q2 2025.